Search PubMed⌕ Search

Biomedical subjects

C A Sargent

Publications and source records attributed to C A Sargent.

60 records · Page 4Linked to original sources

Dietary fish oil and ischaemic arrhythmias.

Ventricular fibrillation (VF), a serious arrhythmia, is an important cause of death from ischaemic heart disease. There is substantial evidence that experimental diets with a high polyunsaturated (linoleic acid) to saturated fatty acid ratio offer protection against VF. In this article the effects of large amounts of dietary fish oil (up to 30% cal) are reviewed. It is concluded that in all recently published studies marked increases in the incorporation of n-3 fatty acids in membranes was achieved. Two studies were too small, however, to demonstrate any statistically significant difference in VF. The results from a third, a long term feeding study, show a reduction in VF when compared with a highly saturated fat diet, but not when compared to a polyunsaturated fatty acid (n-6) rich diet. Using a more realistic fish oil supplement (0.4% cal) for 8 weeks, we observed a small but nonsignificant reduction in the incidence of VF during acute myocardial ischaemia in the isolated perfused rat heart. The need for further work on the effect of dose, dietary period and confounding influences of saturated fatty acids and linoleic acid are discussed.

Animals↗

Molecular mapping of the HLA-linked complement genes and the RCA linkage group.

Phenotypic genetics have established linkage of the genes encoding proteins involved in the activation of the complement component C3. C2, factor B and C4, three of the structural components of the classical and alternative pathway C3 convertases, are encoded by genes which have been mapped to the class III region of the major histocompatibility complex (MHC) on human chromosome 6. The regulatory proteins factor H, C4BP, CR1, CR2 and DAF, which are involved in the control of C3 convertase activity, are encoded by closely linked genes, termed the regulators of complement activation (RCA) linkage group, that have been mapped to human chromosome 1. cDNA clones for all these proteins have been isolated, and this has made it possible to investigate the organization and structure of the MHC class III genes and the genes in the RCA linkage group. This short review summarizes some of the main features which have emerged from recent cloning work.

Animals↗

Molecular mapping of the human major histocompatibility complex by pulsed-field gel electrophoresis.

Pulsed-field gel electrophoresis and "cosmid walking" have been used to establish a molecular map of the human major histocompatibility complex (MHC). We have isolated approximately equal to 230 kilobases (kb) of genomic DNA in overlapping cosmid clones covering the genes for the second and fourth components of complement (C2 and C4, respectively), factor B, and steroid 21-hydroxylase, and approximately equal to 82 kb of genomic DNA surrounding the genes for the tumor necrosis factors alpha and beta. Single-copy hybridization probes isolated from these cosmid clusters and probes for the known MHC gene loci were hybridized to Southern blots of genomic DNA that had been digested with infrequently cutting restriction endonucleases and separated on pulsed-field gels. The data obtained allowed the construction of a long-range genomic restriction map and indicated that the MHC spans 3800 kb. This map orients the MHC class III gene cluster with respect to the DR subregion; the C2 gene is on the telomeric side of the 21-hydroxylase B gene. In addition we have defined the positions of the genes for the tumor necrosis factors alpha and beta in the human MHC. Genes for the alpha chain of DR and 21-hydroxylase B are separated by at least 300 kb, while the distance between the genes for C2 and tumor necrosis factor alpha is 390 kb. The HLA-B locus lies approximately equal to 250 kb on the telomeric side of the tumor necrosis factor genes.

Chromosome Mapping↗